Variants in the CELSR2 gene influence the effectiveness of statins, drugs widely used to manage cholesterol levels, by affecting their pharmacodynamics. This interaction between CELSR2 gene variations and statins highlights the importance of pharmacogenetics in tailoring personalized medication strategies to improve treatment outcomes in patients with cardiovascular conditions.